US brain-computer-interface startup Paradromics is quickly establishing itself as a major player in the neural-device space, ...

Neurotechnology company Paradromics will test its device in a trial aimed at safely restoring speech for people with severe motor impairments.

Alright car enthusiasts and everyday drivers, let’s dive into something crucial for your journey on the road: the ...

The Austin-based startup will test its high-bandwidth device to help restore speech in people with extremely limited movement.

Scientists at UC San Francisco put AI to work analyzing study participants’ gaits, then had it develop personalized brain ...

Paradromics announced that it received FDA investigational device exemption (IDE) to begin a study of its brain-computer interface (BCI).

The ALS Network, in partnership with 12 ALS United member organizations, announces the selection of its 2025 Research Innovation Grantees—an accomplished group of scientists and clinicians whose work ...

Infineon Technologies AG introduces the PSOC 4 HVPA-SPM 1.0, an advanced microcontroller designed for high-voltage Li-ion battery management in electric vehicles (xEVs). The microcontroller combines ...

AstraZeneca’s Alexion division has received FDA approval for Koselugo (selumetinib) to treat adults with NF1 who have symptomatic, inoperable plexiform neurofibromas. The decision is based on strong ...